Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Pear Therapeutics Inc (PEAR)

Pear Therapeutics Inc (PEAR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Pear Therapeutics Inc 200 State Street 13th Floor Boston MA 02109 USA

https://peartherapeutics.com P: 617-925-7848

Sector:

Medical

INDUSTRY GROUPING:

Medical - Drugs

Description:

Pear Therapeutics Inc. is involved in developing and commercializing software-based medicines, called prescription digital therapeutics. The company's principal pipeline of products include reset(R), for the treatment of substance use disorder, reSET-O(R), for the treatment of opioid use disorder and Somryst(R) for the treatment of chronic insomnia. Pear Therapeutics Inc., formerly known as Thimble Point Acquisition Corp., is based in BOSTON.

Key Statistics

Overview:

Market Capitalization, $K 4,168
Enterprise Value, $K -27,722
Shares Outstanding, K 142,739
Float, K 98,918
% Float 69.30%
Short Volume Ratio 0.49
% of Insider Shareholders 30.70%
% of Institutional Shareholders 71.17%

Financials:

Annual Sales, $ 12,690 K
Annual Net Income, $ -75,490 K
Last Quarter Sales, $ 2,570 K
Last Quarter Net Income, $ -26,370 K

Growth:

1-Year Return -99.33%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.22 on 11/14/22
Next Earnings Date 05/15/23
Earnings Per Share ttm -0.70
EPS Growth vs. Prev Qtr 0.00%
EPS Growth vs. Prev Year 12.78%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

PEAR Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -217.85%
Return-on-Assets % -95.20%
Profit Margin % -594.88%
Debt/Equity 0.00
Price/Sales 0.54
Price/Cash Flow N/A
Price/Book 0.13
Book Value/Share 0.22
Interest Coverage 0.00
60-Month Beta 0.45
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.